Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Isis Pharmaceuticals
Biotech
FDA warning letter to IONIS-TTRrx trial site hits Ionis stock
The FDA has sent a warning letter to a trial site studying Ionis Pharmaceuticals’ IONIS-TTRrx.
Nick Paul Taylor
May 11, 2017 4:02am
Atlantic starts rolling FDA submission for antisense drug
May 1, 2017 8:24am
Ionis spinout Akcea files for $100M IPO
Mar 27, 2017 7:50am
Ionis slips as safety concerns offset efficacy in FCS phase 3
Mar 7, 2017 4:53am
